Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway

BACKGROUND: The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has been shown to protect against chronic obstructive pulmonary disease (COPD). The present study aimed to observe the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jindi, Liu, Xuefang, Wei, Yumeng, Lu, Ruilong, Xu, Kexin, Tian, Yange, Li, Jiansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812609/
https://www.ncbi.nlm.nih.gov/pubmed/36619199
http://dx.doi.org/10.1155/2022/9423435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812609/
https://www.ncbi.nlm.nih.gov/pubmed/36619199
http://dx.doi.org/10.1155/2022/9423435

Ejemplares similares